Cargando…

1933. Economic Evaluation of Outpatient Parenteral Antimicrobial Therapy in Children

BACKGROUND: Outpatient parenteral antimicrobial therapy (OPAT) is a safe and effective method to treat serious infections in the home environment. Compared with prolonged hospitalization, OPAT has lower costs and burden on patients and caregivers. However, there is increasing evidence that outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krah, Nathan, Esquibel, Lawanda, Bardsley, Tyler, Nelson, Richard E, Pavia, Andrew, Hersh, Adam L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252447/ http://dx.doi.org/10.1093/ofid/ofy210.1589

Ejemplares similares

Safety and Effectiveness of Outpatient Parenteral Antimicrobial Therapy (OPAT) in the Aged Population
por: Van Anglen, Lucinda J, et al.
Publicado: (2017)

1935. Outpatient Parenteral Antimicrobial Therapy in Nonagenarians
por: Blaskewicz, Caitlin, et al.
Publicado: (2018)

Successful Establishment of an Antimicrobial Stewardship Program (ASP) for Outpatient Parenteral Antimicrobial Therapy (OPAT)
por: Nathan, Ramesh V, et al.
Publicado: (2017)

2059. Antimicrobial Stewardship of Community Parenteral Antimicrobial Therapy: A Health System Approach
por: Buckel, Whitney R, et al.
Publicado: (2019)

Risk Factors for Readmission in Patients with Outpatient Parenteral Antimicrobial Therapy
por: Huang, Victoria, et al.
Publicado: (2017)

1855. Antimicrobial Stewardship (AMS) and the Outpatient Parenteral Antimicrobial Therapy (OPAT) Setting
por: Friedman, N Deborah
Publicado: (2018)

1854. Effective Antimicrobial Stewardship for Outpatient Parenteral Antimicrobial Therapy (OPAT): Nationwide Experience in Infectious Disease Physician Infusion Centers
por: Nathan, Ramesh V, et al.
Publicado: (2018)

330. Outpatient Parenteral Antimicrobial Therapy in People who Inject Drugs
por: Hawes, Armani, et al.
Publicado: (2023)

353. Outpatient parenteral antimicrobial therapy (OPAT) in managing vertebral osteomyelitis
por: Villacorta Cari, Evelyn, et al.
Publicado: (2023)

101. Serious Adverse Event Rates for Cefazolin and Ceftriaxone Outpatient Parenteral Antimicrobial Therapy
por: Sunagawa, Shawnalyn, et al.
Publicado: (2023)

Emergency Department Utilization During Self-Administered Outpatient Parenteral Antimicrobial Therapy
por: Ganguly, Anisha, et al.
Publicado: (2017)

Follow-up Appointment Adherence of Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients
por: Lall, Ambika, et al.
Publicado: (2017)

777. Experience with Liposomal Amphotericin B in Outpatient Parenteral Antimicrobial Therapy (OPAT)
por: Burnett, Yvonne, et al.
Publicado: (2019)

1301. Assessing Safety and Clinical Outcomes of Outpatient Parenteral Antimicrobial Program in Veterans
por: Rich, William, et al.
Publicado: (2023)

325. Outcomes of Outpatient Parenteral Antimicrobial Therapy in the Solid Organ Transplant Population
por: Dillon, William P, et al.
Publicado: (2023)

285. Challenging the Dogmas of Outpatient Parenteral Antimicrobial Therapy Through a Randomized Controlled Trial
por: Ibrahim, Laila, et al.
Publicado: (2018)

Emergency Department Visits During Outpatient Parenteral Antimicrobial Therapy: A Cohort Study
por: Kim, So Lim, et al.
Publicado: (2017)

1939. Socioeconomic Predictors of Hospital Readmission in Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients
por: Hamad, Yasir, et al.
Publicado: (2018)

1027. Outpatient Parenteral Antimicrobial Therapy (OPAT) in Injection Drug Users (IDUs): Is It Safe?
por: Rizvi, Hira, et al.
Publicado: (2018)

597. Comparison of Vancomycin and Daptomycin Complications and Interventions in Outpatient Parenteral Antimicrobial Therapy
por: Nakrani, Monark, et al.
Publicado: (2020)

608. Impact of Implementing Pharmacist Review and Monitoring of Outpatient Parenteral Antimicrobial Therapy
por: Kirkpatrick, Emily R, et al.
Publicado: (2020)

623. Self-Administered Outpatient Parenteral Antimicrobial Therapy (S-OPAT) in Uninsured Patients
por: Hamad, Yasir, et al.
Publicado: (2020)

1926. Evaluation of Safety and Effectiveness of Continuous Infusion Ceftolozane/Tazobactam as Outpatient Parenteral Antimicrobial Therapy
por: Jones, Bruce M, et al.
Publicado: (2018)

1943. Collateral Benefits of Diabetes Management Associated With Self-administered Outpatient Parenteral Antimicrobial Therapy
por: Bhavan, Kavita, et al.
Publicado: (2018)

772. Access Denied: Impact of Insurance Denials for High-Cost Outpatient Parenteral Antimicrobial Therapy
por: Bianchini, Monica L, et al.
Publicado: (2019)

1760. Selection of appropriate inpatients for outpatient parenteral antimicrobial therapy (OPAT) during the COVID pandemic
por: McKnight, Angela Y, et al.
Publicado: (2022)

345. Unaccounted Costs Associated with Different Outpatient Parenteral Antimicrobial Therapy (OPAT) Models of Care
por: Player, Jacob, et al.
Publicado: (2023)

2208. Ten years of the Irish National Outpatient Parenteral Antimicrobial Therapy (OPAT) Registry Data
por: Reidy, Paul, et al.
Publicado: (2023)

OPAT: outpatient parenteral antimicrobial therapy
Publicado: (2020)

Outpatient parenteral antimicrobial therapy in Brazil
por: Oliveira, Priscila R, et al.
Publicado: (2023)

613. Clinical Outcomes Following Dalbavancin Administration during Outpatient Parenteral Antimicrobial Therapy
por: Tuan, Jessica, et al.
Publicado: (2021)

Outpatient Parenteral Antimicrobial Therapy (OPAT) Practices at a Veterans Affairs Hospital: Potential for Pharmacist Impact
por: Yang, Catherine, et al.
Publicado: (2017)

1925. Vancomycin Treatment and Time to Adverse Drug Reactions During Outpatient Parenteral Antimicrobial Therapy (OPAT)
por: Duncan, Asajah, et al.
Publicado: (2018)

1944. Patients With Prosthetic Joint Infections Receiving Outpatient Parenteral Antimicrobial Therapy: Characteristics and Readmission Rates
por: Gore, Sara, et al.
Publicado: (2018)

1941. Comparison of Patient Outcomes in a Pharmacist-Led Outpatient Parenteral Antimicrobial Therapy (OPAT) Program
por: Howe, Zachary, et al.
Publicado: (2018)

1013. Outpatient parenteral antimicrobial therapy (OPAT)-related peripheral eosinophilia as a predictor of hypersensitivity reactions.
por: Khalaf, Suha Abu, et al.
Publicado: (2022)

2081. Low 30-Day Hospital Readmission Rates in Medicare Patients Receiving Outpatient Parenteral Antimicrobial Therapy (OPAT) in Physician Office Infusion Centers
por: Luu, Quyen, et al.
Publicado: (2019)

600. Decreased Hospital Readmission After Programmatic Strengthening of an Outpatient Parenteral Antimicrobial Therapy (OPAT) Program
por: Agnihotri, Gaurav, et al.
Publicado: (2020)

1932. Healthcare Utilization in Older vs. Younger Adults on Outpatient Parenteral Antimicrobial Therapy According to Discharge Location
por: Datta, Rupak, et al.
Publicado: (2018)

755. Outpatient Parenteral Antimicrobial Therapy Program Evaluation within a Large Veterans Affairs Healthcare System
por: Kent, Michael, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bj2rjgog00t1gincetuho4n7jf